CHJTF (CSPC Pharmaceutical Group) Common Stock : $1,517 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Common Stock?

CSPC Pharmaceutical Group's quarterly common stock declined from Dec. 2023 ($1,526 Mil) to Mar. 2024 ($0 Mil) but then increased from Mar. 2024 ($0 Mil) to Jun. 2024 ($1,517 Mil).

CSPC Pharmaceutical Group's annual common stock declined from Dec. 2021 ($1,711 Mil) to Dec. 2022 ($1,563 Mil) and declined from Dec. 2022 ($1,563 Mil) to Dec. 2023 ($1,526 Mil).

CSPC Pharmaceutical Group Common Stock Historical Data

The historical data trend for CSPC Pharmaceutical Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Common Stock Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

1,554.02

1,666.76

1,711.24

1,563.38

1,526.49

CSPC Pharmaceutical Group Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial															-	1,526.49	-	1,517.06	-

CSPC Pharmaceutical Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

CSPC Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

CSPCY:USA 01093:Hong Kong CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group Headlines

From GuruFocus

Value Partners Classic Fund Comments on CSPC Pharmaceutical

By Vera Yuan Vera Yuan • 07-29-2014